<- Go Home
ImpediMed Limited
ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema, and deliver snapshot of fluid status and tissue composition; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.
Market Cap
AUD 119.4M
Volume
3.0M
Cash and Equivalents
AUD 36.9M
EBITDA
-AUD 22.9M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
AUD 9.1M
Profit Margin
86.95%
52 Week High
AUD 0.21
52 Week Low
AUD 0.06
Dividend
N/A
Price / Book Value
2.34
Price / Earnings
-5.78
Price / Tangible Book Value
3.35
Enterprise Value
AUD 83.7M
Enterprise Value / EBITDA
-3.66
Operating Income
-AUD 23.6M
Return on Equity
42.36%
Return on Assets
-27.58
Cash and Short Term Investments
AUD 36.9M
Debt
AUD 1.3M
Equity
AUD 51.0M
Revenue
AUD 10.5M
Unlevered FCF
-AUD 14.6M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium